European Equity pre-Market Summary - 10th September 2026: European bourses set for a mildly firmer open; Porsche AG lifts guidance
European bourses point to a firmer open led by Porsche AG raising cash flow guidance, while healthcare firms Bayer and Roche secure key FDA regulatory milestones.
News detail
Stories: IG Group (IGG LN): Co. is reportedly cutting hundreds of jobs from its 2300 strong workforce. Porsche AG (P911 GY), +0.7%: Announces the sale of its stakes in Bugatti Rimac and Rimac Group for c. EUR 1bln. Co. also raises its FY Automotive Net Cash Flow Margin to +5.5-7.5% (prev. guided 3-5%). Bayer (BAYN GY), +0.5%: Announces that the US FDA has granted accelerated approval for HYRNUO. Roche (ROP SW): Co. announces that the US FDA has granted Priority Review to a supplemental Biologics License Application for Enspryng for the treatment of MOGAD, based on positive results from the Phase III METEOROID study. Broker Moves: BAE Systems (BA/ LN) initiated with Neutral at BNP Paribas. Novartis (NOVN SW), +0.5% upgraded to Hold from Reduce at HSBC. Fortum (FORTUM FH), +0.7% received a broker upgrade at four banks. The numbers after the Co. & ticker are the pre-market indication via Tradegate
What do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
